Abbvie Inc Stock Price Patterns
| ABBV Stock | USD 224.16 4.56 1.99% |
Momentum 0
Sell Peaked
Oversold | Overbought |
Quarterly Earnings Growth (0.89) | EPS Estimate Next Quarter 3.1001 | EPS Estimate Current Year 14.551 | EPS Estimate Next Year 16.0275 | Wall Street Target Price 246.2593 |
Using AbbVie hype-based prediction, you can estimate the value of AbbVie Inc from the perspective of AbbVie response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards AbbVie using AbbVie's stock options and short interest. It helps to benchmark the overall future attitude of investors towards AbbVie using crowd psychology based on the activity and movement of AbbVie's stock price.
AbbVie Short Interest
An investor who is long AbbVie may also wish to track short interest. As short interest increases, investors should be becoming more worried about AbbVie and may potentially protect profits, hedge AbbVie with its derivative instruments, or be ready for some potential downside.
200 Day MA 210.6259 | Short Percent 0.0111 | Short Ratio 2.86 | Shares Short Prior Month 19.7 M | 50 Day MA 223.7996 |
AbbVie Inc Hype to Price Pattern
Investor biases related to AbbVie's public news can be used to forecast risks associated with an investment in AbbVie. The trend in average sentiment can be used to explain how an investor holding AbbVie can time the market purely based on public headlines and social activities around AbbVie Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of AbbVie's market sentiment to its price can help taders to make decisions based on the overall investors consensus about AbbVie.
AbbVie Implied Volatility | 0.37 |
AbbVie's implied volatility exposes the market's sentiment of AbbVie Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if AbbVie's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that AbbVie stock will not fluctuate a lot when AbbVie's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in AbbVie to buy its stock at a price that has no basis in reality. In that case, they are not buying AbbVie because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
AbbVie after-hype prediction price | USD 228.68 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current AbbVie contract
Based on the Rule 16, the options market is currently suggesting that AbbVie Inc will have an average daily up or down price movement of about 0.0231% per day over the life of the 2026-05-15 option contract. With AbbVie trading at USD 224.16, that is roughly USD 0.0518 . If you think that the market is fully incorporating AbbVie's daily price movement you should consider acquiring AbbVie Inc options at the current volatility level of 0.37%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out AbbVie Basic Forecasting Models to cross-verify your projections. AbbVie After-Hype Price Density Analysis
As far as predicting the price of AbbVie at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in AbbVie or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of AbbVie, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
AbbVie Estimiated After-Hype Price Volatility
In the context of predicting AbbVie's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on AbbVie's historical news coverage. AbbVie's after-hype downside and upside margins for the prediction period are 227.09 and 230.27, respectively. We have considered AbbVie's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
AbbVie is very steady at this time. Analysis and calculation of next after-hype price of AbbVie Inc is based on 3 months time horizon.
AbbVie Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as AbbVie is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading AbbVie backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with AbbVie, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.03 | 1.59 | 0.04 | 0.06 | 7 Events / Month | 6 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
224.16 | 228.68 | 0.02 |
|
AbbVie Hype Timeline
AbbVie Inc is presently traded for 224.16. The entity has historical hype elasticity of -0.04, and average elasticity to hype of competition of 0.06. AbbVie is forecasted to decline in value after the next headline, with the price expected to drop to 228.68. The average volatility of media hype impact on the company price is about 115.22%. The price decrease on the next news is expected to be -0.02%, whereas the daily expected return is presently at -0.03%. The volatility of related hype on AbbVie is about 80.83%, with the expected price after the next announcement by competition of 224.22. About 76.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.39. AbbVie Inc last dividend was issued on the 16th of January 2026. Given the investment horizon of 90 days the next forecasted press release will be in about 7 days. Check out AbbVie Basic Forecasting Models to cross-verify your projections.AbbVie Related Hype Analysis
Having access to credible news sources related to AbbVie's direct competition is more important than ever and may enhance your ability to predict AbbVie's future price movements. Getting to know how AbbVie's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how AbbVie may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| JNJ | Johnson Johnson | 4.07 | 5 per month | 0.28 | 0.32 | 1.87 | (0.96) | 5.56 | |
| AZN | AstraZeneca PLC | 4.68 | 7 per month | 1.82 | 0.11 | 4.09 | (2.96) | 10.86 | |
| NVS | Novartis AG ADR | 0.81 | 7 per month | 0.74 | 0.24 | 2.57 | (2.06) | 6.07 | |
| NVO | Novo Nordisk AS | 0.08 | 5 per month | 3.58 | (0) | 5.80 | (5.58) | 23.77 | |
| MRK | Merck Company | 0.23 | 5 per month | 0.98 | 0.25 | 2.93 | (1.98) | 8.74 | |
| UNH | UnitedHealth Group Incorporated | 7.78 | 34 per month | 0.00 | (0.08) | 3.02 | (2.67) | 24.28 | |
| AMGN | Amgen Inc | (4.85) | 6 per month | 1.43 | 0.09 | 3.47 | (2.62) | 11.13 | |
| GILD | Gilead Sciences | 6.90 | 6 per month | 1.27 | 0.17 | 3.01 | (2.56) | 8.38 | |
| PFE | Pfizer Inc | (0.13) | 6 per month | 1.30 | 0.05 | 2.40 | (2.42) | 6.01 | |
| SNY | Sanofi ADR | 0.10 | 5 per month | 0.00 | (0.16) | 1.51 | (2.20) | 6.81 |
AbbVie Additional Predictive Modules
Most predictive techniques to examine AbbVie price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for AbbVie using various technical indicators. When you analyze AbbVie charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About AbbVie Predictive Indicators
The successful prediction of AbbVie stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as AbbVie Inc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of AbbVie based on analysis of AbbVie hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to AbbVie's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to AbbVie's related companies. | 2023 | 2025 | 2026 (projected) | Dividend Yield | 0.0385 | 0.0287 | 0.0283 | Price To Sales Ratio | 5.04 | 6.69 | 3.57 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for AbbVie Stock Analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.